| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.088 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |